West Texas Pharmacology Core will serve two purposes. One is helping academic researchers and biotech companies to develop new anti-cancer drugs. The other is promoting discoveries in new therapies for childhood cancers. CPRIT also has been providing funding to researchers and biotech companies with innovative ideas in developing a new therapy for cancer. One of the critical components of drug development is to study how the drug behaves in humans, especially in cancer patients. This is especially important to eliminate those drug candidates that won't make it as drugs before they are tested in cancer patients as human studies are very costly, and they may not help the patients. Pharmacolog...

Read More

West Texas Pharmacology Core will serve two purposes. One is helping academic researchers and biotech companies to develop new anti-cancer drugs. The other is promoting discoveries in new therapies for childhood cancers. CPRIT also has been providing funding to researchers and biotech companies with innovative ideas in developing a new therapy for cancer. One of the critical components of drug development is to study how the drug behaves in humans, especially in cancer patients. This is especially important to eliminate those drug candidates that won't make it as drugs before they are tested in cancer patients as human studies are very costly, and they may not help the patients. Pharmacology is one of the critical components in deciding go-no-go decisions on drug candidates, and thus it is required to conduct such studies. However, many academic researchers and small biotech companies have limited access to pharmacology services due to the expertise required and resources required. Also, childhood cancer has been one of the focus areas of CPRIT, and more recently federal government revised law to mandate biotech companies to develop drugs for childhood cancers. Our team of researchers is highly experienced in developing drugs from laboratory science to clinical trials, especially in childhood cancers. The team's expertise in pharmacology will help cancer researchers and biotech companies in Texas develop their drug candidates.

Read Less